Abstract

CABI is a not-for-profit international organization with the mission of improving people’s lives worldwide by solving problems in agriculture and the environment, while engendering trust and facilitating science. As an organisation CABI is both a provider and a user of biological control agents and regularly acting as an intermediary between provider and user countries. As a way of building trust between both sides, access and benefit sharing (ABS) policy and ABS best practices developed around the principles of the Nagoya protocol should be publicly accessible. CABI aims to facilitate compliance with national legislation on ABS through its best practices for the countries in which we work and those that we provide genetic resources. CABI adopted the position to share benefits whether the provider country is party to the Nagoya Protocol or not. We use a case study on the biological control of the coffee berry borer (Hypothenemus hampei (Ferrari)) to illustrate the implementation of ABS best practices for the overlap between biological control and ABS. In respect to Digital Sequence Information (DSI) associated with genetic resources CABI contributes to the ongoing global debate and evaluates how this may impact biocontrol research and delivery. The current view is that publishing sequence data is sharing descriptive information and thus delivers benefit-sharing from its generation. However, if DSI is used in a product placed on the market, there is justification for benefit sharing.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call